Galapagos and Cancer Research Technology announce new anti-cancer drug discovery collaboration

20-Jan-2006

Galapagos NV and Cancer Research Technology ("CRT") announced that they have entered into a new collaboration in anti-cancer drug discovery research. Under the terms of the agreement Galapagos' service division BioFocus will perform medicinal chemistry services on a series of CRT anti-cancer drug programs. In return, CRT will fund the work of four BioFocus scientists throughout 2006.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...